Venture Visionary Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.56M | Buy |
80,609
+19,110
| +31% | +$1.32M | 0.21% | 114 |
|
2025
Q1 | $4.27M | Buy |
61,499
+57,812
| +1,568% | +$4.01M | 0.18% | 126 |
|
2024
Q4 | $317K | Sell |
3,687
-2,200
| -37% | -$189K | 0.01% | 442 |
|
2024
Q3 | $701K | Buy |
5,887
+68
| +1% | +$8.1K | 0.03% | 319 |
|
2024
Q2 | $831K | Buy |
5,819
+1,901
| +49% | +$271K | 0.04% | 300 |
|
2024
Q1 | $503K | Buy |
3,918
+1,019
| +35% | +$131K | 0.02% | 373 |
|
2023
Q4 | $300K | Buy |
2,899
+19
| +0.7% | +$1.97K | 0.02% | 428 |
|
2023
Q3 | $262K | Sell |
2,880
-136
| -5% | -$12.4K | 0.02% | 429 |
|
2023
Q2 | $244K | Sell |
3,016
-86
| -3% | -$6.96K | 0.01% | 443 |
|
2023
Q1 | $247K | Buy |
3,102
+146
| +5% | +$11.6K | 0.02% | 437 |
|
2022
Q4 | $200K | Buy |
+2,956
| New | +$200K | 0.01% | 453 |
|
2022
Q3 | – | Sell |
-3,244
| Closed | -$181K | – | 1185 |
|
2022
Q2 | $181K | Buy |
+3,244
| New | +$181K | 0.01% | 466 |
|